# Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine

> **NCT00370227** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 390 (—)

## Conditions studied

- Infections, Streptococcal

## Interventions

- **BIOLOGICAL:** 10 valent pneumococcal conjugate (vaccine)

## Key facts

- **NCT ID:** NCT00370227
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 390 (—)
- **Last updated:** 2016-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00370227

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00370227, "Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00370227. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*